Liver News and Research

RSS

Review of recent advances in stem cell biology

Advances in stem cell research will provide enormous opportunities for both biological and future clinical applications.

4 Aug 2014

Bacteria that aid in digestion help keep intestinal lining intact

Scientists at Albert Einstein College of Medicine of Yeshiva University have found that bacteria that aid in digestion help keep the intestinal lining intact.

4 Aug 2014

Research helps explain why brain tumors occur more often in males

New research at Washington University School of Medicine in St. Louis helps explain why brain tumors occur more often in males and frequently are more harmful than similar tumors in females.

3 Aug 2014

MUP policy for alcohol is targeted towards heaviest drinkers with cirrhosis

A new study of liver patients by the University of Southampton shows that a Minimum Unit Price (MUP) policy for alcohol is exquisitely targeted towards the heaviest drinkers with cirrhosis.

1 Aug 2014

Study reveals new information about body clock's sway over metabolism

Much of the liver's metabolic function is governed by circadian rhythms - our own body clock - and UC Irvine researchers have now found two independent mechanisms by which this occurs.

1 Aug 2014

State highlights: Maryland's top health official leaving for Johns Hopkins; Minnesota lawmakers to propose legislation to require contraception coverage

Maryland's top health official, Joshua M. Sharfstein, announced Wednesday that he will leave at the end of Gov. Martin O'Malley's term in January to become an associate dean at the Johns Hopkins Bloomberg School of Public Health (Johnson, 7/30).

1 Aug 2014

Researchers to study multi-faceted approaches to address issues of burnout in transplant surgeons

Despite saving thousands of lives yearly, nearly half of organ transplant surgeons report a low sense of personal accomplishment and 40% feel emotionally exhausted, according to a new national study on transplant surgeon burnout.

29 Jul 2014

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The Lancet.

29 Jul 2014

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1200 HEV-containing blood components (eg, red cells, platelets, and fresh frozen plasma) are likely to be transfused every year in England.

29 Jul 2014

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

Veloxis Pharmaceuticals A/S and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.

28 Jul 2014

New study in recognition of World Hepatitis Day released on Life Sciences Connect

The Intellectual Property and Science business of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today released a new study in recognition of World Hepatitis Day on Life Sciences Connect, a blog exploring the latest news and trends in Life Sciences and updates on the drug pipeline identifying multiple treatments in development that may serve as potential alternatives to Gilead's Sovaldi, currently priced in the United States at $84,000 for 12 weeks of treatment - $1000 per pill.

28 Jul 2014

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

A new in vitro study has revealed that nicotine and cotinine, a metabolite of nicotine, can potentially inhibit DNA damage caused by a certain carcinogen in smoke.

28 Jul 2014

Researchers provide global genotype prevalence estimates for HCV

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver Diseases, indicate that genotype 1 is the most prevalent worldwide, with over 83 million patients infected of which one-third reside in East Asia.

28 Jul 2014

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Scientists from INRA in collaboration with a Chinese team found that the gut microbiota[1] of individuals with liver cirrhosis differ notably from healthy individuals', showing a high proportion of oral bacteria.

26 Jul 2014

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

The Chemistry, Food & Drugs Division of the Trinidad & Tobago Ministry of Health approved the introduction of Telaprevir to the market, an innovative therapy that significantly increases the cure rate from Hepatitis C, and it is indicated for patients infected with the genotype 1 virus. Telaprevir is available in Trinidad under the trade brand INCIVO®.

26 Jul 2014

Xbp1s protein plays key role in brain regions to regulate metabolism

A protein that controls when genes are switched on or off plays a key role in specific areas of the brain to regulate metabolism, UT Southwestern Medical Center researchers have found.

26 Jul 2014

Viewpoints: Ryan's 'thoughtful blueprint' to end poverty; GOP challenges after health law ruling

The Republican chairman of the House Budget Committee today released a thoughtful blueprint for overhauling $800 billion worth of U.S. anti-poverty programs.

26 Jul 2014

Researchers examine effects of bacteria in fighting against obesity

A probiotic that prevents obesity could be on the horizon. Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, Vanderbilt University investigators have discovered.

26 Jul 2014

RI Defeats Hepatitis C project aims to eliminate HCV in Rhode Island

Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection program, states in the July, 2014 Rhode Island Medical Journal special edition, "RI Defeats Hep C" that eliminating hepatitis c virus infection (hep c or HCV) is feasible, can provide economic benefits, enhance capacity to address other health challenges, and improve health care disparities.

26 Jul 2014

Unique bacterial biomarkers may help develop diagnostics, treatments for liver cirrhosis

ENTEROME Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, and with a strong focus on liver diseases, highlights the advanced online publication in Nature of a research paper describing the identification of a unique series of bacterial biomarkers that could provide new opportunities for the development of diagnostics and treatments for liver cirrhosis.

26 Jul 2014

Liver News and Research

Review of recent advances in stem cell biology

Bacteria that aid in digestion help keep intestinal lining intact

Research helps explain why brain tumors occur more often in males

MUP policy for alcohol is targeted towards heaviest drinkers with cirrhosis

Study reveals new information about body clock's sway over metabolism

State highlights: Maryland's top health official leaving for Johns Hopkins; Minnesota lawmakers to propose legislation to require contraception coverage

Researchers to study multi-faceted approaches to address issues of burnout in transplant surgeons

New pill-only antiviral drug regimens could cure hardest-to-treat hepatitis C

First systematic analysis indicates that about 1 in 3000 donors in England have HEV

Envarsus gets marketing authorization from EC for treatment of kidney and liver transplant patients

New study in recognition of World Hepatitis Day released on Life Sciences Connect

Nicotine, cotinine can potentially inhibit DNA damage caused by NNK in tobacco smoke

Researchers provide global genotype prevalence estimates for HCV

Scientists find high proportion of oral bacteria in gut microbiota of liver cirrhosis patients

Trinidad & Tobago Ministry of Health approves hepatitis C drug telaprevir

Xbp1s protein plays key role in brain regions to regulate metabolism

Viewpoints: Ryan's 'thoughtful blueprint' to end poverty; GOP challenges after health law ruling

Researchers examine effects of bacteria in fighting against obesity

RI Defeats Hepatitis C project aims to eliminate HCV in Rhode Island

Unique bacterial biomarkers may help develop diagnostics, treatments for liver cirrhosis

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News